TEPYLUTE

THIOTEPA · Shorla Oncology Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TEPYLUTE, covering 2024-06-25 to 2025-12-09. Get the full timeline:

Most recent: FDA Approved: TEPYLUTE — Supplemental Application (Shorla Oncology Inc.)